Onward Medical Statistics

Total Valuation

Onward Medical has a market cap or net worth of EUR 194.43 million. The enterprise value is 149.47 million.

Market Cap	194.43M
Enterprise Value	149.47M

Important Dates

The next estimated earnings date is Tuesday, June 17, 2025.

Earnings Date	Jun 17, 2025
Ex-Dividend Date	n/a

Share Statistics

Onward Medical has 44.65 million shares outstanding. The number of shares has increased by 47.86% in one year.

Current Share Class	44.65M
Shares Outstanding	44.65M
Shares Change (YoY)	+47.86%
Shares Change (QoQ)	+57.77%
Owned by Insiders (%)	6.45%
Owned by Institutions (%)	17.14%
Float	26.28M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	111.81
PB Ratio	4.05
P/TBV Ratio	5.17
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-4.18
EV / Sales	85.95
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-4.68

Financial Position

The company has a current ratio of 6.85, with a Debt / Equity ratio of 0.31.

Current Ratio	6.85
Quick Ratio	6.57
Debt / Equity	0.31
Debt / EBITDA	n/a
Debt / FCF	-0.47
Interest Coverage	-17.61

Financial Efficiency

Return on equity (ROE) is -108.28% and return on invested capital (ROIC) is -44.47%.

Return on Equity (ROE)	-108.28%
Return on Assets (ROA)	-36.37%
Return on Invested Capital (ROIC)	-44.47%
Return on Capital Employed (ROCE)	-52.13%
Revenue Per Employee	16,883
Profits Per Employee	-346,845
Employee Count	103
Asset Turnover	0.03
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -7.93% in the last 52 weeks. The beta is 0.85, so Onward Medical's price volatility has been lower than the market average.

Beta (5Y)	0.85
52-Week Price Change	-7.93%
50-Day Moving Average	4.40
200-Day Moving Average	5.04
Relative Strength Index (RSI)	57.14
Average Volume (20 Days)	62,483

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Onward Medical had revenue of EUR 1.74 million and -35.73 million in losses. Loss per share was -0.80.

Revenue	1.74M
Gross Profit	-12.17M
Operating Income	-34.84M
Pretax Income	-35.77M
Net Income	-35.73M
EBITDA	-34.51M
EBIT	-34.84M
Loss Per Share	-0.80

Full Income Statement

Balance Sheet

The company has 60.04 million in cash and 15.09 million in debt, giving a net cash position of 44.96 million or 1.01 per share.

Cash & Cash Equivalents	60.04M
Total Debt	15.09M
Net Cash	44.96M
Net Cash Per Share	1.01
Equity (Book Value)	48.05M
Book Value Per Share	1.08
Working Capital	54.33M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -31.76 million and capital expenditures -150,000, giving a free cash flow of -31.91 million.

Operating Cash Flow	-31.76M
Capital Expenditures	-150,000
Free Cash Flow	-31.91M
FCF Per Share	-0.71

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-2,003.68%
Pretax Margin	-2,056.64%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Onward Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-47.86%
Shareholder Yield	-47.86%
Earnings Yield	-18.37%
FCF Yield	-16.41%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Onward Medical has an Altman Z-Score of -0.31. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.31
Piotroski F-Score	n/a